In the final stage, the drug is packaged into boxes, vials or pens ... Eli Lilly’s weight-loss drug; and Stelara, Johnson & Johnson’s anti-inflammatory drug used for conditions like arthritis.

Its key products include anti-inflammation drug Stelara, multiple myeloma and light ... filling sterile drugs into containers such as vials and syringes and preparing them for distribution.

Healthcare & Pharmaceuticalscategory· February 25, 2025 Lilly offers weight-loss drugs in vials at a discount to ... J&J sues Samsung Bioepis over Stelara biosimilar Johnson & Johnson sued ...

The concerns around the Stelara exclusivity appear overblown. China’s new tariffs just reignited the same market patterns that led to triple- and quadruple-digit wins for Matt Maley. Get the ...

Johnson & Johnson (J&J) has announced that Stelara (ustekinumab) has been approved by the European Commission (EC) to treat moderately to severely active Crohn’s disease (CD) in paediatric patients.

Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out Penfill cartridges. This decision follows concerns about the discontinuation ...

BAT2206, the proposed biosimilar to J&J’s Stelara, is a human monoclonal antibody with a unique mechanism of action that has potential in treating Crohn's disease and ulcerative colitis ...

Among the most significant milestones was the launch of ustekinumab biosimilars following the loss of exclusivity for Stelara. This expansion has played a pivotal role in fostering market ...